Back to Search

ALFRED GARCIA, M.D.

M.D.

Anatomic Pathology & Clinical Pathology Physician

NPI: 1871884569IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Anatomic Pathology & Clinical Pathology PhysicianPrimary

Pathology — Anatomic Pathology & Clinical Pathology

Code: 207ZP0102X

A119403(CA)

CMS Specialties

PrimaryPATHOLOGY

Education

OTHER

Class of 2010

Research & Publications (20)

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
PMID 18165643·J Clin Oncol·2008
3-trial
A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
PMID 18675446·Gynecol Oncol·2008
3-trial
Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis.
PMID 16379039·Invest New Drugs·2006
3-trial
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study.
PMID 15721430·Gynecol Oncol·2005
3-trial
Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.
PMID 15809878·Cancer Chemother Pharmacol·2005
3-trial
Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
PMID 16377584·Cancer Invest·2005
3-trial
GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain.
PMID 15494728·Nat Neurosci·2004
4-observational
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.
PMID 15099968·Gynecol Oncol·2004
3-trial
Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.
PMID 15361639·Int J Gastrointest Cancer·2003
3-trial
Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.
PMID 12448655·Invest New Drugs·2002
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
1200 N STATE ST, PATHOLOGY, CLINIC TOWER A7E
LOS ANGELES, CA 90033

Quick Facts

NPI
1871884569
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
16
Publications
20

Are you this provider?

Claim Your Profile